1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 4:Analysis of refractures within 1 year
Percentage of Patients Having a Second Treatment Session Within 1 y of Initial Procedure Percentage of Refractured Patients Having a Third Treatment Session Within 1 y of Initial Procedure Average Available Cement Volumes for Patients Refracuring Within 1 y of Initial Procedure (cc) Average Time Between Treatment Sessions for Refracturing Patients Within 1 y of Initial Procedures No. of Patients Having Initial Procedure No. Refractured (2nd Procedure) % Refracturing No. Refractured (2nd Procedure) No. Refractured (3rd Procedure) % of Refractured Patients Having 3rd Procedure Δt Between 1st and 2nd procedure wk Δt Between 2nd and 3rd procedure wk Primary osteoporosis 350 72 20.6 72 23 31.9% 5.18 ± 2.58 11.3 12 Steroid-induced osteoporosis 37 14 37.8 14 6 42.9% 5.97 ± 3.02 7.93 10.8 Total 387 86 22.2 86 29 33.7% Relative risk 1.84 1.34† P value .0163 .3094
* Chi-squared analysis.
† Fisher exact test.